High Country Venture
The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado.
Business Model: B2B
Revenue: $10.5M
Employees: 2-10
Rankings
Industries / Tags:
Detailed High Country Venture Information
Geographic Data
Address: 831 Pearl St
City: Boulder
State: CO
Zip: 80302
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado. The fund will focus its investments in Life Sciences (including biotechnology, clean technology, and medical devices), information technology (including software and Internet companies) and retail. They encourage all qualified businesses in rural areas who are seeking capital to submit a business plan, regardless of the industry you are in.
Contact Phone:
+13033812638
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2014 | Nutrinsic | Series C | 12.7M |
| 9/2010 | Documoto | Seed Round | 1.2M |
| 5/2015 | Documoto | Series B | 9M |
| 7/2008 | Sierra Neuropharmaceuticals Inc. | Series A | 0 |
| 5/2015 | Kapost | Venture Round | 0 |
| 9/2011 | FullContact | Seed Round | 1.9M |
| 11/2011 | Mosaic Biosciences | Series A | 1M |
| 7/2011 | Cool Energy | Venture Round | 1M |
| 11/2007 | LogRhythm | Series A | 3.3M |
| 1/2012 | Mosoro | Series A | 0 |
| 8/2005 | Taligen Therapeutics | Series A | 3.8M |
| 1/2008 | Taligen Therapeutics | Series B | 65M |
| 8/2013 | FitBionic | Unattributed | 2.2M |
| 11/2011 | TriSalus Life Sciences | Series A | 6.1M |
| 8/2008 | Envysion | Series C | 0 |
| 2/2007 | Envysion | Series B | 0 |
| 1/2012 | Kapost | Venture Round | 1.5M |
| 8/2010 | Taligen Therapeutics | Series B | 10M |
| 11/2013 | Collective IP | Series A | 2.5M |
| 4/2009 | LogRhythm | Series B | 3.1M |
| 4/2015 | Nutrinsic | Venture Round | 1.6M |
| 7/2013 | Documoto | Series A | 3M |
| 1/2012 | Qualvu | Series B | 1.9M |
| 4/2011 | Sovrn | Venture Round | 11M |
| 11/2013 | TriSalus Life Sciences | Series B | 0 |
| 8/2007 | Nutrinsic | Series A | 1M |
| 7/2012 | FullContact | Series A | 7M |
| 12/2015 | TriSalus Life Sciences | Series C | 0 |
| 11/2013 | Covalent Data | Series A | 0 |
| 4/2016 | Covalent Data | Series A | 0 |
| 9/2010 | Documoto | Venture Round | 1.2M |
| 12/2013 | Nutrinsic | Series B | 12.7M |
| 12/2008 | Nutrinsic | Debt Financing | 675k |
| 9/2010 | Kapost | Series A | 1.1M |
| 7/2013 | Kapost | Venture Round | 5.6M |
| 4/2016 | Covalent Data | Series A | 0 |
| 12/2015 | TriSalus Life Sciences | Series C | 0 |
| 5/2015 | Kapost | Venture Round | 0 |
| 5/2015 | Documoto | Series B | 0 |
| 4/2015 | Nutrinsic | Venture Round | 0 |
| 8/2014 | Nutrinsic | Series C | 0 |
| 12/2013 | Nutrinsic | Series B | 0 |
| 11/2013 | Collective IP | Series A | 0 |
| 11/2013 | Covalent Data | Series A | 0 |
| 11/2013 | TriSalus Life Sciences | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
